SITADAC

Introduction:
The SITADAC product line is a comprehensive range of oral antihyperglycemic agents designed for the effective management of type 2 diabetes mellitus. Featuring Sitagliptin phosphate as the core DPP-4 inhibitor, along with strategic combinations with Metformin and Dapagliflozin, SITADAC offers flexible, patient-centric treatment options for optimal glycemic control. Available in premium ALU-ALU blister packaging (10 x 10 tablets), SITADAC ensures superior product stability, moisture protection, and extended shelf life.

Product Range & Benefits

SITADAC-50

• Composition: Sitagliptin phosphate 50 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Ideal for initial DPP-4 inhibitor therapy in patients with mild to moderate type 2 diabetes.

SITADAC-100

• Composition: Sitagliptin phosphate 100 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Standard once-daily therapy for comprehensive glycemic control in type 2 diabetes.

SITADAC-M

• Composition: Sitagliptin phosphate 50 mg + Metformin 500 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Dual-action combination for enhanced glycemic control targeting both incretin hormones and hepatic glucose production.

SITADAC-M 1000

• Composition: Sitagliptin phosphate 50 mg + Metformin 1000 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Higher-strength Metformin combination for patients requiring intensive blood sugar management.

SITADAC-D 25

• Composition: Sitagliptin 25 mg + Dapagliflozin 10 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Triple-mechanism combination (DPP-4 inhibitor + SGLT2 inhibitor) for patients with renal impairment or those needing lower Sitagliptin dose.

SITADAC-D 100

• Composition: Sitagliptin 100 mg + Dapagliflozin 10 mg

• Packaging: ALU-ALU, 10 x 10 Tablets

• Use: Advanced combination therapy for robust glycemic control with additional cardiovascular and renal protective benefits.

Indications:

• Type 2 diabetes mellitus (as monotherapy or combination therapy)

• Adjunct to diet and exercise to improve glycemic control

• In combination with Metformin, Sulfonylureas, or Insulin

• Reduction of cardiovascular and renal risks (Dapagliflozin-containing combinations)

• Patients with chronic kidney disease (SITADAC-D 25)

Dosage and Administration:

• SITADAC-50 / SITADAC-100: One tablet once daily, with or without food.

• SITADAC-M / SITADAC-M 1000: One tablet twice daily with meals to reduce gastrointestinal side effects.

• SITADAC-D 25 / SITADAC-D 100: One tablet once daily in the morning.

• Dose adjustments required for renal impairment (eGFR based).

• Regular monitoring of HbA1c, fasting and postprandial blood glucose is recommended.

Precautions & Warnings:

• Contraindicated in type 1 diabetes mellitus and diabetic ketoacidosis.

• Use cautiously in patients with renal impairment, hepatic disease, or history of pancreatitis.

• Metformin-containing products: Risk of lactic acidosis; monitor renal function before and during treatment.

• Dapagliflozin-containing products: Risk of genital mycotic infections, volume depletion, and rare cases of Fournier’s gangrene or ketoacidosis.

• Discontinue immediately if symptoms of pancreatitis (severe abdominal pain) occur.

• Not recommended during pregnancy and lactation.

Possible Side Effects:

• Upper respiratory tract infection, nasopharyngitis

• Headache, gastrointestinal discomfort (nausea, diarrhea)

• Hypoglycemia (when combined with sulfonylureas or insulin)

• Pancreatitis (rare but serious)

• Metformin-containing: Nausea, vomiting, metallic taste, lactic acidosis (very rare)

• Dapagliflozin-containing: Genital fungal infections, urinary tract infections, increased urination, dehydration

Conclusion:
The SITADAC range – including SITADAC-50, SITADAC-100, SITADAC-M, SITADAC-M 1000, SITADAC-D 25, and SITADAC-D 100 – provides flexible, evidence-based solutions for managing type 2 diabetes. Whether initiating monotherapy or requiring advanced combination therapy, SITADAC delivers reliable glycemic control with added cardiovascular and renal protection.

If you’re looking to buy Sitagliptin and combination tablets online or for clinical use, trust the SITADAC range for proven efficacy, premium ALU-ALU packaging, and patient-friendly formulations.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Diabetic

You can also contact us  https://diabetes-cardiac.com/contact-us/